PolyrizonNASDAQ: PLRZ

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

Israel

IPO:

29 October 2024

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$3.86 M
-45%vs. 3y high
10%vs. sector
-vs. 3y high
-vs. sector
-148.42
-13%vs. 3y high
1%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Thu, 21 Nov 2024 14:30:00 GMT
$0.92-$0.03(-2.65%)

Dividend

No data over the past 3 years
No data over the past 3 years
No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

Included in screeners

No data

What type of business is Polyrizon?

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a containment barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

What sector is Polyrizon in?

Polyrizon is in the Healthcare sector

What industry is Polyrizon in?

Polyrizon is in the Biotechnology industry

What country is Polyrizon from?

Polyrizon is headquartered in Israel

When did Polyrizon go public?

Polyrizon initial public offering (IPO) was on 29 October 2024

What is Polyrizon website?

https://www.polyrizon-biotech.com

Is Polyrizon in the S&P 500?

No, Polyrizon is not included in the S&P 500 index

Is Polyrizon in the NASDAQ 100?

No, Polyrizon is not included in the NASDAQ 100 index

Is Polyrizon in the Dow Jones?

No, Polyrizon is not included in the Dow Jones index

When was Polyrizon the previous earnings report?

No data

When does Polyrizon earnings report?

Next earnings report date is not announced yet